Familial Lecithin:Cholesterol Acyltransferase Deficiency: First-in-Human Treatment with Enzyme Replacement

BACKGROUND: Humans with familial lecithin:cholesterol acyltransferase (LCAT) deficiency (FLD) have extremely low or undetectable HDL-C levels and by early adulthood develop many manifestations of the disorder, including corneal opacities, anemia, and renal disease. OBJECTIVE: To determine if infusio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Lipidol
Autores principales: Shamburek, Robert D., Bakker-Arkema, Rebecca, Auerbach, Bruce J., Krause, Brian R., Homan, Reynold, Amar, Marcelo J., Freeman, Lita A., Remaley, Alan T.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826469/
https://ncbi.nlm.nih.gov/pubmed/27055967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacl.2015.12.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares